Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Behavioural Dysfunction Questionnaire discriminates behavioural variant frontotemporal dementia from Alzheimer's disease dementia and major depressive disorder.
Semenkova A, Piguet O, Johnen A, Schroeter ML, Godulla J, Linnemann C, Mühlhauser M, Sauer T, Baumgartner M, Anderl-Straub S, Otto M, Felbecker A, Kressig RW, Berres M, Sollberger M. Semenkova A, et al. Among authors: sauer t. J Neurol. 2023 Jul;270(7):3433-3441. doi: 10.1007/s00415-023-11666-6. Epub 2023 Mar 23. J Neurol. 2023. PMID: 36952011 Free PMC article.
Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment.
Ronnacker J, Ruhnke L, Röllig C, Middeke JM, Herbst R, Morgner A, Unglaub JM, Sauer T, Huber K, Baden D, Fransecky L, Gezer MN, Crysandt M, Jost E, Jentzsch M, Metzeler KH, Berdel AF, Urbahn MA, Kolloch L, Stelljes M, Platzbecker U, Brümmendorf TH, Baldus C, Müller-Tidow C, Hänel M, Bornhäuser M, Wethmar K, Krug U, Lenz G, Mikesch JH, Schliemann C. Ronnacker J, et al. Among authors: sauer t. Leukemia. 2025 Jul 3. doi: 10.1038/s41375-025-02675-7. Online ahead of print. Leukemia. 2025. PMID: 40603653 No abstract available.
Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma.
Kourtesakis A, Bailey E, Chow HNH, Rohdjeß H, Mussnig N, Agardy DA, Hoffmann DCF, Chih YC, Will R, Kaulen L, Hahn M, Wagener R, Reibold D, Pusch S, Sahm F, Sauer T, Schmitt M, Bunse L, Platten M, Wick W, Kessler T. Kourtesakis A, et al. Among authors: sauer t. Oncoimmunology. 2025 Dec;14(1):2518631. doi: 10.1080/2162402X.2025.2518631. Epub 2025 Jun 15. Oncoimmunology. 2025. PMID: 40518621 Free PMC article.
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.
Rautenberg C, Middeke JM, Röllig C, Stelljes M, Gaidzik V, Kriege O, Verbeek M, Koch K, Unglaub JM, Thol F, Krause SW, Hänel M, Neuerburg C, Vucinic V, Jehn CF, Wass M, Heuser M, Fransecky L, Chemnitz J, Holtick U, Schäfer-Eckart K, Schröder J, Kraus S, Krüger W, Kaiser U, Scholl S, Kobbe G, Jäger PS, Alakel N, von Bonin M, Sockel K, Hanoun M, Platzbecker U, Holderried TAW, Morgner A, Sauer T, Götze KS, Wagner-Drouet E, Döhner K, Döhner H, Schliemann C, Schetelig J, Bornhäuser M, Germing U, Flossdorf S, Schroeder T, Stölzel F. Rautenberg C, et al. Among authors: sauer t. Blood Cancer J. 2025 Apr 8;15(1):60. doi: 10.1038/s41408-025-01274-0. Blood Cancer J. 2025. PMID: 40199848 Free PMC article. No abstract available.
The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML.
Stasik S, Eckardt JN, Röllig C, Baldus CD, Platzbecker U, Serve H, Müller-Tidow C, Schäfer-Eckart K, Kaufmann M, Krause SW, Sauer T, Hänel M, Neubauer A, Ehninger G, Bornhäuser M, Schetelig J, Middeke JM, Thiede C; Study Alliance Leukemia (SAL). Stasik S, et al. Among authors: sauer t. Br J Haematol. 2025 May;206(5):1373-1379. doi: 10.1111/bjh.20027. Epub 2025 Mar 5. Br J Haematol. 2025. PMID: 40041934 Free PMC article.
451 results